Literature DB >> 28101764

Diazepam in the Treatment of Moderate to Severe Alcohol Withdrawal.

Steven J Weintraub1,2.   

Abstract

Benzodiazepines ameliorate or prevent the symptoms and complications of moderate to severe alcohol withdrawal, which can include autonomic hyperactivity, agitation, combativeness, hallucinations, seizures, delirium, and death. The benzodiazepines most commonly used for this purpose are lorazepam, chlordiazepoxide, oxazepam, and diazepam. It is widely asserted that no member of this group is superior to the others for treatment of alcohol withdrawal. However, of these, diazepam has the shortest time to peak effect, which facilitates both rapid control of symptoms and accurate titration to avoid over-sedation. Furthermore, diazepam and its active metabolite, desmethyldiazepam, have the longest elimination half-lives, so their levels decrease in a gradual, self-tapering manner, resulting in a smoother withdrawal, i.e., a lower incidence and severity of both breakthrough symptoms and rebound phenomena, including a possibly decreased seizure risk. Importantly, the fear of increased risk of over-sedation with diazepam compared with other benzodiazepines is based on a misunderstanding of its pharmacokinetics and is unfounded. Similarly, the notion that diazepam should be avoided in patients with liver disease and elderly patients to avoid prolonged over-sedation is based on no more than conjecture. In fact, there is clinical evidence that diazepam is safe for the treatment of alcohol withdrawal in these patients when administered using a simple symptom-based approach. There is one instance in which diazepam should not be used: when intramuscular administration is the only option, the lipophilicity of diazepam can result in slow absorption-either lorazepam or, when rapid control of symptoms is required, midazolam should be used. The comparative pharmacokinetics of the benzodiazepines used in the treatment of alcohol withdrawal together with a comprehensive review of the literature on their use strongly suggest that diazepam should be the preferred benzodiazepine for the treatment of patients experiencing moderate to severe alcohol withdrawal under most circumstances.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28101764     DOI: 10.1007/s40263-016-0403-y

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  76 in total

1.  COMPARATIVE CLINICAL EVALUATION OF CHLORDIAZEPOXIDE AND PROMAZINE IN TREATMENT OF ALCOHOL-WITHDRAWAL SYNDROME.

Authors:  G SERENY; H KALANT
Journal:  Br Med J       Date:  1965-01-09

Review 2.  Management of the alcohol withdrawal syndrome.

Authors:  M K Romach; E M Sellers
Journal:  Annu Rev Med       Date:  1991       Impact factor: 13.739

3.  Diazepam loading in alcohol withdrawal: clinical pharmacokinetics.

Authors:  P Heinälä; T Piepponen; H Heikkinen
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1990-05

Review 4.  Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.

Authors:  Guy Chouinard
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

5.  Management of alcohol withdrawal delirium. An evidence-based practice guideline.

Authors:  Michael F Mayo-Smith; Lee H Beecher; Timothy L Fischer; David A Gorelick; Jeanette L Guillaume; Arnold Hill; Gail Jara; Chris Kasser; John Melbourne
Journal:  Arch Intern Med       Date:  2004-07-12

6.  Midazolam: an effective intravenous agent for seizure control.

Authors:  G M Galvin; G A Jelinek
Journal:  Arch Emerg Med       Date:  1987-09

7.  A randomized, double-blind comparison of lorazepam and chlordiazepoxide in patients with uncomplicated alcohol withdrawal.

Authors:  Channaveerachari Naveen Kumar; Chittaranjan Andrade; Pratima Murthy
Journal:  J Stud Alcohol Drugs       Date:  2009-05       Impact factor: 2.582

8.  Absolute bioavailability of oral and intramuscular diazepam: effects of age and sex.

Authors:  M Divoll; D J Greenblatt; H R Ochs; R I Shader
Journal:  Anesth Analg       Date:  1983-01       Impact factor: 5.108

Review 9.  Alcohol withdrawal: what is the benzodiazepine of choice?

Authors:  R D Bird; E H Makela
Journal:  Ann Pharmacother       Date:  1994-01       Impact factor: 3.154

10.  Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines.

Authors:  A Kales; M B Scharf; J D Kales; C R Soldatos
Journal:  JAMA       Date:  1979-04-20       Impact factor: 56.272

View more
  7 in total

Review 1.  Pharmacotherapies for decreasing maladaptive choice in drug addiction: Targeting the behavior and the drug.

Authors:  Frank N Perkins; Kevin B Freeman
Journal:  Pharmacol Biochem Behav       Date:  2017-06-27       Impact factor: 3.533

2.  Preventive Effects of Baclofen but Not Diazepam on Hippocampal Memory and Glucocorticoid Alterations After Prolonged Alcohol Withdrawal in Mice.

Authors:  Henkous Nadia; Martins Fabienne; Christophe Pierard; Mons Nicole; Beracochea Daniel
Journal:  Front Psychiatry       Date:  2022-05-24       Impact factor: 5.435

3.  Efficacy of transcutaneous electrical acupoint stimulation combined with diazepam for acute alcohol withdrawal syndrome: A double-blind randomized sham-controlled trial.

Authors:  Yun Song; Xiaobin Xue; Haibin Han; Cuiluan Li; Jia Jian; Wei Yuan; Xu Chen
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

4.  Pregabalin abuse and dependence during insomnia and protocol for short-term withdrawal management with diazepam: examples from case reports.

Authors:  Basavaraja Papanna; Carlo Lazzari; Kapil Kulkarni; Sivasankar Perumal; Abdul Nusair
Journal:  Sleep Sci       Date:  2021 Apr-Jun

5.  The Use of Anticonvulsant Adjuncts to Treat Alcohol Withdrawal Syndrome in Older Adults.

Authors:  Stefanie Montgomery; Karen Dahri; Kaveh Rayani; Jacqueline Kwok; Peter Chan
Journal:  Can Geriatr J       Date:  2022-03-02

Review 6.  Targeting the Glucocorticoid Receptors During Alcohol Withdrawal to Reduce Protracted Neurocognitive Disorders.

Authors:  Daniel Béracochéa; Nicole Mons; Vincent David
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

7.  Clinical characteristics and health outcomes in patients with alcohol withdrawal syndrome: an observational study from Oman.

Authors:  Juhaina Salim Al-Maqbali; Nasiba Al-Maqrashi; Aisha Al-Huraizi; Qasim Sultan Al-Mamari; Khalifa Al Alawa; Abdullah M Al Alawi
Journal:  Ann Saudi Med       Date:  2022-02-03       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.